Education
About Us
Working with TipRanks
Follow Us
Starpharma Holdings Limited (AU:SPL)
:SPL
Total Valuation
Starpharma Holdings Limited has a market cap or net worth of AU$152.65M. The enterprise value is AU$23.80M.
Market CapAU$152.65M
Enterprise ValueAU$23.80M
Share Statistics
Starpharma Holdings Limited has 418,224,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding418,224,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Starpharma Holdings Limited’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -9.15%.
Return on Equity (ROE)-0.53
Return on Assets (ROA)-0.39
Return on Invested Capital (ROIC)-9.15%
Return on Capital Employed (ROCE)-0.59
Revenue Per Employee122.80K
Profits Per Employee0.00
Employee Count40
Asset Turnover0.19
Inventory Turnover0.64
Valuation Ratios
The current PE Ratio of Starpharma Holdings Limited is ―. Starpharma Holdings Limited’s PEG ratio is -0.19.
PE Ratio―
PS Ratio7.47
PB Ratio1.93
Price to Fair Value1.93
Price to FCF-5.40
Price to Operating Cash Flow-27.53
PEG Ratio-0.19
Income Statement
In the last 12 months, Starpharma Holdings Limited had revenue of 4.91M and earned -9.99M in profits. Earnings per share was -0.02.
Revenue4.91M
Gross Profit3.69M
Operating Income-12.00M
Pretax Income-9.99M
Net Income-9.99M
EBITDA-10.93M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -6.76M and capital expenditures -42.00K, giving a free cash flow of -6.80M billion.
Operating Cash Flow-6.76M
Free Cash Flow-6.80M
Free Cash Flow per Share-0.02
Dividends & Yields
Starpharma Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change247.62%
50-Day Moving Average0.35
200-Day Moving Average0.17
Relative Strength Index (RSI)47.82
Average Volume (3m)781.04K
Important Dates
Starpharma Holdings Limited upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
Starpharma Holdings Limited as a current ratio of 4.32, with Debt / Equity ratio of 12.64%
Current Ratio4.32
Quick Ratio3.95
Debt to Market Cap0.01
Net Debt to EBITDA1.19
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Starpharma Holdings Limited has paid -8.36M in taxes.
Income Tax-8.36M
Effective Tax Rate0.84
Enterprise Valuation
Starpharma Holdings Limited EV to EBITDA ratio is -2.17, with an EV/FCF ratio of -3.49.
EV to Sales4.83
EV to EBITDA-2.17
EV to Free Cash Flow-3.49
EV to Operating Cash Flow-3.51
Balance Sheet
Starpharma Holdings Limited has AU$15.41M in cash and marketable securities with AU$2.40M in debt, giving a net cash position of AU$13.01M billion.
Cash & Marketable SecuritiesAU$15.41M
Total DebtAU$2.40M
Net CashAU$13.01M
Net Cash Per ShareAU$0.03
Tangible Book Value Per ShareAU$0.05
Margins
Gross margin is -63.74%, with operating margin of -244.26%, and net profit margin of -203.38%.
Gross Margin-63.74%
Operating Margin-244.26%
Pretax Margin-203.38%
Net Profit Margin-203.38%
EBITDA Margin-222.48%
EBIT Margin-244.26%
Analyst Forecast
The average price target for Starpharma Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-40.74%
EPS Growth Forecast-21.21%